ALLEGRO PHARMACEUTICALS LLC has a total of 19 patent applications. Its first patent ever was published in 2010. It filed its patents most often in United States, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are COHBAR INC, FAVRILLE INC and ONCLAVE THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Republic of Korea | 2 | |
#4 | Brazil | 1 | |
#5 | Israel | 1 | |
#6 | Japan | 1 | |
#7 | Mexico | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Object sterilising | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Park John Y | 9 |
#2 | Karageozian Hampar L | 9 |
#3 | Karageozian Vicken H | 9 |
#4 | Mackel Michael John | 5 |
#5 | Park John | 5 |
#6 | Vicken H Karageozian | 4 |
#7 | John Y Park | 4 |
#8 | Hampar L Karageozian | 4 |
#9 | Karageozian Vicken | 1 |
#10 | Karageozian Hampar | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021021668A1 | Peptides for treating non-exudative macular degeneration and other disorders of the eye | |
EP3570867A2 | Therapeutic and neuroprotective peptides |